Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: Modulation by ischemic preconditioning

American Journal of Physiology - Renal Physiology

Volumn 291, Issue 1, 2006, Pages

  Patschan, Daniel ^a   Krupincza, Krystina ^a   Patschan, Susann ^a   Zhang, Zhongtao ^a   Hamby, Carl ^a   Goligorsky, Michael S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Acute renal failure; EPCs; Ischemia associated mobilization; Renal ischemia protection; Renal stem cells

Indexed keywords

ANGIOPOIETIN RECEPTOR; GREEN FLUORESCENT PROTEIN; STEM CELL FACTOR;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENAL ARTERY; RENAL PROTECTION; STEM CELL; TISSUE REPAIR;

EID: 33745345861     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00454.2005     Document Type: Article

References (32)

1. Adams V, Lenk K, Linke A, Lenz D, Erbs S, Sandri M, Tarnok A, Gielen S, Emmrich F, Schuler G, and Hambrecht R. Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arterioscler Thromb Vasc Biol 24: 684-690, 2004.
2. Arriero M, Brodsky SV, Gealekman O, Lucas PA, and Goligorsky MS. Adult skeletal muscle stem cells differentiate into endothelial lineage and ameliorate renal dysfunction after acute ischemia. Am J Physiol Renal Physiol 287: F621-F627, 2004.
3. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, and Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228, 1999.
4. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, and Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997.
5. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, and Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106: 3009-3017, 2002.
6. Bolli R. The late phase of preconditioning. Circ Res 87: 972-983, 2000.
7. Bonventre JV. Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 11: 43-48, 2002.
8. Bonventre JV and Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int 66: 480-485, 2004.
9. Brodsky SV, Yamamoto T, Tada T, Kim B, Chen J, Kajiya F, and Goligorsky MS. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 282: F1140-F1149, 2002.
10. Carden DL and Granger DN. Pathophysiology of ischemia-reperfusion injury. J Pathol 190: 255-266, 2000.
11. 2+ influx. J Leukoc Biol 78: 266-278, 2005.
12. Deten A, Volz HC, Clamors S, Leiblein S, Briest W, Marx G, and Zimmer HG. Hematopoietic stem cells do not repair the infarcted mouse heart. Cardiovasc Res 65: 52-63, 2005.
13. Flores J, DiBona DR, Beck CH, and Leaf A. The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J Clin Invest 51: 118-126, 1972.
14. Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathil T, Sher F, O'Rourke F, Nasser AM, Schwindt B, and Todd K. Endothelial progenitor cells during cerebrovascular disease. Stroke 36: 151-153, 2005.
15. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, and Dimmeler S. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102: 1340-1346, 2003.
16. Herget-Rosenthal S, Marggraf G, Husing J, Goring F, Pietruck F, Janssen O, Philipp T, and Kribben A. Early detection of acute renal failure by serum cystatin C. Kidney Int 66: 1115-1122, 2004.
17. Ii M, Nishimura H, Iwakura A, Wecker A, Eaton E, Asahara T, and Losordo DW. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation 111: 1114-1120, 2005.
18. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, and Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97: 3422-3427, 2000.
19. Lambiase PD, Edwards RJ, Anthopoulos P, Rahman S, Meng YG, Bucknall CA, Redwood SR, Pearson JD, and Marber MS. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation 109: 2986-2992, 2004.
20. Leaf A. Cell swelling. A factor in ischemic tissue injury. Circulation 48: 455-458, 1973.
21. Miura T and Tsuchida A. Adenosine and preconditioning revisited. Clin Exp Pharmacol Physiol 26: 92-99, 1999.
22. O'Neill TJ IV, Wamhoff BR, Owens GK, and Skalak TC. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 97: 1027-1035, 2005.
23. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, and Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98: 10344-10349, 2001.
24. Papayannopoulou T and Craddock C. Homing and trafficking of hemopoietic progenitor cells. Acta Haematol 97: 97-104, 1997.
25. Park K, Chen A, and Bonventre J. Prevention of kidney ischemia/reperfusioninduced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 276: 11870-11876, 2001.
26. Schrier RW and Wang W. Acute renal failure and sepsis. N Engl J Med 351: 159-169, 2004.
27. Schuster MD, Kocher AA, Seki T, Martens TP, Xiang G, Homma S, and Itescu S. Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. Am J Physiol Heart Circ Physiol 287: H525-H532, 2004.
28. Summers WK and Jamison RL. The no reflow phenomenon in renal ischemia. Lab Invest 25: 635-643, 1971.
29. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, and Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438, 1999.
30. Urbich C and Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95: 343-353, 2004.
31. Urbich C, Heeschen C, Aicher A, Sasaki K, Bruhl T, Farhadi MR, Vajkoczy P, Hofmann WK, Peters C, Pennacchio LA, Abolmaali ND, Chavakis E, Reinheckel T, Zeiher AM, and Dimmeler S. Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat Med 11: 206-213, 2005.
32. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, and Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-E7, 2001.